Share this video  

SABCS 2021 | Molecular heterogeneity in HER2+ breast cancer and predicting outcomes

Aleix Prat, MD, PhD, Hospital Clinic Barcelona, Barcelona, Spain, provides an overview of molecular heterogeneity in HER2+ breast cancer, discussing biological features linked to clinical outcomes including intrinsic subtyping. This interview took place at the San Antonio Breast Cancer Symposium 2021 in San Antonio.